Brief: Atara Biotherapeutics Q2 EPS USD -3.1
12/08/2024 22:00
Aug 12 (Reuters) - Atara Biotherapeutics Q2 operating income USD -18.231 million. * Q2 revenue USD 28.64 million vs. IBES estimate USD 40 million * Q2 net income USD -19.049 million
Recent news on Atara Biotherapeutics
See all newsAtara Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atara Biotherapeutics Q2 revenue falls on deferred revenue recognition
Brief: Atara Biotherapeutics Q2 EPS USD -0.32
Atara Biotherapeutics, Inc. expected to post a loss of 31 cents a share - Earnings Preview
Brief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing